# Effect of TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure

> **NCT05469503** · NA · UNKNOWN · sponsor: **Valbiotis** · enrollment: 410 (actual)

## Conditions studied

- Prehypertension
- Elevated Blood Pressure
- Blood Pressure
- Metabolic Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** TOTUM-854
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT05469503
- **Lead sponsor:** Valbiotis
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-15
- **Primary completion:** 2024-09-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 410 (ACTUAL)
- **Last updated:** 2024-04-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05469503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05469503, "Effect of TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05469503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*